JP2009521532A5 - - Google Patents

Download PDF

Info

Publication number
JP2009521532A5
JP2009521532A5 JP2008548581A JP2008548581A JP2009521532A5 JP 2009521532 A5 JP2009521532 A5 JP 2009521532A5 JP 2008548581 A JP2008548581 A JP 2008548581A JP 2008548581 A JP2008548581 A JP 2008548581A JP 2009521532 A5 JP2009521532 A5 JP 2009521532A5
Authority
JP
Japan
Prior art keywords
polymer
neutral
composition
component
film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008548581A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009521532A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/047927 external-priority patent/WO2007075422A2/en
Publication of JP2009521532A publication Critical patent/JP2009521532A/ja
Publication of JP2009521532A5 publication Critical patent/JP2009521532A5/ja
Pending legal-status Critical Current

Links

JP2008548581A 2005-12-27 2006-12-14 活性物質を放出するための、pH調節されたフィルム Pending JP2009521532A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75409205P 2005-12-27 2005-12-27
PCT/US2006/047927 WO2007075422A2 (en) 2005-12-27 2006-12-14 Ph modulated films for delivery of actives

Publications (2)

Publication Number Publication Date
JP2009521532A JP2009521532A (ja) 2009-06-04
JP2009521532A5 true JP2009521532A5 (enExample) 2010-02-12

Family

ID=38218457

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008548581A Pending JP2009521532A (ja) 2005-12-27 2006-12-14 活性物質を放出するための、pH調節されたフィルム

Country Status (8)

Country Link
US (1) US20110166240A1 (enExample)
EP (1) EP1968558B1 (enExample)
JP (1) JP2009521532A (enExample)
CN (1) CN101346135A (enExample)
AU (1) AU2006329819A1 (enExample)
CA (1) CA2631431A1 (enExample)
ES (1) ES2624003T3 (enExample)
WO (1) WO2007075422A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2699077T3 (es) 2009-06-12 2019-02-07 Sunovion Pharmaceuticals Inc Apomorfina sublingual
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
EP2493457B1 (en) 2009-10-30 2017-08-09 IX Biopharma Ltd Fast dissolving solid dosage form
EA031156B1 (ru) 2010-12-16 2018-11-30 Суновион Фармасьютикалз Инк. Сублингвальные пленки
CN107823721B (zh) * 2013-05-02 2021-01-29 德国凯德诺有限责任公司 球囊表面涂层
WO2016172095A1 (en) 2015-04-21 2016-10-27 Cynapsus Therapeutics, Inc. Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
US20170042551A1 (en) 2015-08-13 2017-02-16 The Brain Protection Company PTY LTD Implantable damping devices for treating dementia and associated systems and methods of use
CN108676085B (zh) * 2018-07-03 2019-09-24 北京六盛合医药科技有限公司 一种胸腺法新的制备方法及其药物组合物
JP7353364B2 (ja) * 2018-07-11 2023-09-29 キュア ファーマシューティカル, インコーポレイテッド 口腔内速崩壊性フィルム剤マトリックス
CN113727658A (zh) 2018-12-04 2021-11-30 脑部保护私人有限公司 包括用于治疗病症的可植入阻尼装置和治疗剂的组合疗法及相关系统和使用方法
US20210130752A1 (en) * 2019-11-05 2021-05-06 The Procter & Gamble Company Substrates having water-soluble polymer zones comprising a freshening active and consumer products comprising the same
WO2021119737A1 (en) 2019-12-16 2021-06-24 The Brain Protection Company PTY LTD A device and method for altering blood flow characteristics in a vessel

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755558A (en) * 1971-02-23 1973-08-28 Du Pont Polylactide drug mixtures for topical application atelet aggregation
US4950689A (en) * 1987-03-31 1990-08-21 Yang Robert K Pectin delivery system
JPH09187233A (ja) * 1996-01-12 1997-07-22 Ota Seiyaku Kk ゼリー組成物
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US6699315B2 (en) * 2000-11-28 2004-03-02 Fmc Corporation Edible PGA coating composition
US6932861B2 (en) * 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
JP2004099558A (ja) * 2002-09-11 2004-04-02 Medorekkusu:Kk 医薬用ゼリー組成物
KR100548925B1 (ko) * 2002-10-23 2006-02-02 한미약품 주식회사 약물의 경구투여용 서방성 조성물
JP2007528357A (ja) * 2003-04-14 2007-10-11 エフ エム シー コーポレーション ゲルフィルムを製造するための方法
WO2005011637A1 (ja) * 2003-08-04 2005-02-10 Eisai Co., Ltd. 用時分散型製剤
WO2005040228A2 (en) * 2003-10-24 2005-05-06 Adhesives Research, Inc. Disintegratable films for diagnostic devices
JP4413665B2 (ja) * 2004-03-19 2010-02-10 救急薬品工業株式会社 口腔内粘膜フィルム剤
KR100598326B1 (ko) * 2004-04-10 2006-07-10 한미약품 주식회사 HMG-CoA 환원효소 억제제의 경구투여용 서방형 제제및 이의 제조방법

Similar Documents

Publication Publication Date Title
JP2009521532A5 (enExample)
JP6042815B2 (ja) 生物医学的応用のためのアルギン酸塩及びヒアルロン酸を用いる抗癒着性バリア膜
TWI609710B (zh) 奈米薄膜轉印片、奈米薄膜轉印片之製造方法、及將奈米薄膜層轉印至被附著物之方法
JP2010189416A5 (enExample)
Chen et al. Pectinate nanofiber mat with high absorbency and antibacterial activity: A potential superior wound dressing to alginate and chitosan nanofiber mats
JP5572263B2 (ja) ヒアルロン酸またはその誘導体の担持薄膜および薄膜化粧料
US10195410B2 (en) Fabrication process of phase-transition microneedle patch
CN102657899B (zh) 防止血管再狭窄的药物涂层支架及其制备方法
JP2017506924A5 (enExample)
Zhou et al. Preparation and application of hemostatic hydrogels
FI2752203T3 (fi) Hemostaattinen aine
Yuan et al. Advances in biomedical application of nanocellulose-based materials: a review
JP2004534030A5 (enExample)
CN102380102A (zh) 一种环境响应性介孔硅纳米粒子的制备方法
JP2013514093A5 (enExample)
JPH06510330A (ja) 多糖フォームの製造方法
CN101524543A (zh) 一种止血凝胶膜剂
CN103566415B (zh) 一种双面涂层的人体血管植入物及其制作方法
JP2008531742A5 (enExample)
WO2010039644A3 (en) Supercritical fluid loading of porous medical devices with bioactive agents
Trembecka-Wójciga et al. A comprehensive review of graphene-based aerogels for biomedical applications. The impact of synthesis parameters onto material microstructure and porosity
CZ20113A3 (cs) Zdravotní prípravek tvorící jód, zpusob jeho prípravy a bandáž, která jej obsahuje
EP3978234A1 (en) Nanomesh multilayer body, method for producing conductive circuit and nanomesh bonding kit
JP2010512252A5 (enExample)
Cao et al. Metal–organic gels: recent advances in their classification, characterization, and application in the pharmaceutical field